Navigation Links
Elekta Highlights Latest Version of MOSAIQ Oncology Information System at HIMSS12 Meeting
Date:2/16/2012

ATLANTA, Feb.16, 2012 /PRNewswire/ – Acknowledging the importance of dedicated information management systems for radiation and medical oncology practices, Elekta will demonstrate the most recent version of its MOSAIQ® Oncology Information System (OIS) at the Healthcare Information and Management Systems Society's 2012 conference (HIMSS12), Feb. 20-24, in Las Vegas.

MOSAIQ is a comprehensive OIS that centralizes traditional radiation oncology, particle therapy and medical oncology patient data into a single user interface, accessible by multidisciplinary teams across multiple locations. MOSAIQ provides hospitals and oncology staff access to the underlying clinical and administrative data, improving both clinical care and operational efficiency.

Visitors to Elekta booth #1455 will learn how MOSAIQ integrates with a diverse array of hospital systems, treatment devices and imaging systems, increasing accessibility to critical data anytime by remote users on various platforms. MOSAIQ captures the entire patient chart in a common database that users can customize, allowing radiation oncologists and medical oncologists to coordinate care for complex cases. In addition to hospital based centers, MOSAIQ provides all the clinical, administrative and billing needs allowing the stand alone centers to have one, complete, comprehensive oncology system. 

MOSAIQ is "Best in KLAS" for 2011
At a HIMSS presentation, MOSAIQ will be recognized for its number one ranking in the recently released 2011 Best in KLAS Awards: Software & Services report. The report is a summary of performance data collected over the past 12 months and ranks the top overall vendors.

"MOSAIQ integrates with hundreds of hospital and laboratory systems at facilities around the world," says Todd Powell, Executive Vice President, Elekta Software. "We are enormously gratified that our customer respondents in the KLAS survey recognized the value of MOSAIQ for managing their patients' care. I believe it clearly demonstrates the strengths of the MOSAIQ community and how we collectively develop and support each other in our common goal of effectively managing cancer."

KLAS's data are also supported by the U.S. News & World Report 2011-12 best hospital rankings, which indicate that 46 out of the 50 top-ranked cancer hospitals are users of Elekta's oncology software.

To learn more, visit www.elekta.com/mosaiq.

About Elekta
Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both healthcare providers and patients, Elekta aims to improve, prolong and even save patient lives.

Today, Elekta solutions in oncology and neurosurgery are used in over 6,000 hospitals worldwide. Elekta employs around 3,300 employees globally. The corporate headquarters is located in Stockholm, Sweden, and the company is listed on the Nordic Exchange under the ticker EKTAb. Website: www.elekta.com.

 


'/>"/>
SOURCE Elekta
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Elekta Announces Clinical Start-Up of New Leksell Gamma Knife(R) Perfexion(TM) at UPMC
2. IBA and Elekta Initiate Global Particle Therapy Program at ASTRO
3. First Clinical Volumetric Modulated Arc Therapy Treatment Completed With Elekta Synergy(R) S at General Hospital Vienna
4. Elektas New Line of Stereotactic Treatment Solutions is Redefining Excellence in Stereotaxy, a Case at a Time
5. Seattles Swedish Cancer Institute First in U.S. to Treat Cancer Patient with Elekta VMAT
6. CMS, Inc., an Elekta Company, Announces First Cancer Patients Treated With Monaco(TM) Radiation Treatment Planning System
7. Massachusetts General Hospital Selects Elekta As New Vendor for Complete Cancer Treatment Solution
8. National Intrepid Center of Excellence To Combat Traumatic Brain Injury With Sophisticated Brain Mapping Technology From Elekta
9. Elekta Provides Complete Planning, Treatment and Workflow Solution for Roy and Patricia Disney Family Cancer Center
10. Elekta Demonstrates Continued Leadership in Image Guidance at 2009 ASTRO Annual Meeting
11. Elekta Expands Consultative Services Program to Help MOSAIQ Customers Demonstrate Meaningful Use Guidelines
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... , December 5, 2016 PharmaBoardroom today releases ... . ... This report offers companies, investors, policymakers, and stakeholders crucial insight ... of Europe , home to some of the world,s ... pharmaceutical companies in Novartis and Roche, and with a number one ranking ...
(Date:12/5/2016)... and TAIPEI, Taiwan , Dec. 5, 2016 ... treatment ropeginterferon alfa-2b showed non-inferiority to hydroxyurea (HU) in Complete ... better safety and tolerability profile of ropeginterferon alfa-2b versus HU ... and the ongoing long-term follow-up trial CONTINUATION-PV to obtain European ... intends to present this data to the FDA as it ...
(Date:12/4/2016)... Attorney General of Louisiana , Charles ... firm of Kahn Swick & Foti, LLC ("KSF"), announces that ... LCI ). On November 3, ... in Generic-Drug Probe to Be Filed by Year-End," which reported ... two years ago, now spans more than a dozen companies," ...
Breaking Medicine Technology:
(Date:12/5/2016)... ... December 05, 2016 , ... As renowned, board-certified dermatologists, Dr. Sabrina G. Fabi ... patients who do not do their research and undergo cosmetic dermatology treatments from unqualified ... midst of a renaissance and every other month a new treatment or device is ...
(Date:12/5/2016)... ... December 05, 2016 , ... ... CardioQuick Patch® significantly improves the reproducibility and accuracy of placing precordial electrodes with ... , Over the last 60 years, studies have shown that single electrode ...
(Date:12/4/2016)... ... ... James Earl Jones is known for myriad roles on stage and screen, he has ... the forthcoming episodes examines mammogram techniques; a very important part of preventative medicine. , ... detection. Like any other disease, treatments have a much higher chance of success if ...
(Date:12/4/2016)... ... December 04, 2016 , ... Patients who wish to gain ... of a cosmetic procedure known as Carbon Dioxide (C02) Fractional Laser Resurfacing ... age spots, fine lines, uneven coloration, wrinkles, scarring, skin laxity or textural ...
(Date:12/2/2016)... ... 02, 2016 , ... Lori G. Cohen and Sara K. ... at the American Conference Institute’s 21st Drug & Medical Device Litigation Conference , ... of the conference. , Cohen, who chairs the firm’s Pharmaceutical, Medical Device & Health ...
Breaking Medicine News(10 mins):